Seminars in Hematology
Volume 45, Issue 3 , Pages 141-149 , July 2008

Bayesian Interpretation and Analysis of Research Results

  • Sander Greenland

      Affiliations

    • Corresponding Author InformationAddress correspondence to Sander Greenland, Department of Epidemiology and Department of Statistics, University of California, Los Angeles, CA 90095-1772.

References 

  1. Greenland S. Bayesian perspectives for epidemiologic research (I. Foundations and basic methods). Int J Epidemiol. 2006;35:765–778
  2. Greenland S. Bayesian perspectives for epidemiologic research (II. Regression analysis). Int J Epidemiol. 2007;36:195–202
  3. Greenland S. Probability logic and probabilistic induction. Epidemiology. 1998;9:322–332
  4. Greenland S, Lash TL. Bias analysis. In:  Rothman KJ,  Greenland S,  Lash TL editor. Modern Epidemiology. ed 3. Philadelphia, PA: Lippincott Williams & Wilkins; 2008;p. 345–380
  5. Greenland S. Multiple-bias modeling for analysis of observational data (with discussion). J R Stat Soc A. 2005;168:267–308
  6. Greenland S. Randomization, statistics, and causal inference. Epidemiology. 1990;1:421–429
  7. Greenland S, Lanes SF, Jara M. Estimating efficacy from randomized trials with discontinuations: The need for intent-to-treat design and g-estimation. Clin Trials. 2008;5:5–13
  8. Savitz DA, Wachtel H, Barnes FA, John EM, Tvrdik JG. Case-control study of childhood cancer and exposure to 60-Hz magnetic fields. Am J Epidemiol. 1988;128:21–38
  9. Leonard T, Hsu JSJ. Bayesian Methods. Cambridge, UK: Cambridge University Press; 1999;
  10. Efron B, Morris CN. Data analysis using Stein's estimator and its generalizations. J Am Stat Assoc. 1975;70:311–319
  11. Leamer E. Specification Searches. New York, NY: Wiley; 1978;
  12. Taubes G. Fields of fear. The Atlantic. 1994;274:94–100
  13. United Kingdom Childhood Cancer Study. Exposure to power-frequency magnetic fields and the risk of childhood cancer. Lancet. 1999;354:1925–1931
  14. Good I. Good Thinking. Minneapolis, MN: University of Minnesota Press; 1983;
  15. Matthews R. Methods for assessing the credibility of clinical trial outcomes. Drug Inform J. 2001;35:1469–1478
  16. Higgins JPT, Spiegelhalter DJ. Being skeptical about meta-analyses: A Bayesian perspective on magnesium trials in myocardial infarction. Int J Epidemiol. 2000;31:96–104
  17. Greenland S. Prior data for non-normal priors. Stat Med. 2007;26:3578–3590
  18. Spielgelhalter DJ, Abrams KR, Myles JP. Bayesian Approaches to Clinical Trials and Health-Care Assessment. London, UK: Wiley; 2004;
  19. Box GEP. Sampling and Bayes inference in scientific modelling and robustness (with discussion). J R Stat Soc A. 1980;143:383–430
  20. Greenland S. Generalized conjugate priors for Bayesian analysis of risk and survival regressions. Biometrics. 2003;59:92–99

PII: S0037-1963(08)00063-2

doi: 10.1053/j.seminhematol.2008.04.004

Seminars in Hematology
Volume 45, Issue 3 , Pages 141-149 , July 2008

Article Tools